<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g358" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-354.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-341.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-351.html" >Vaccine-Preventable STDs</a><span class="carrot"> > </span>
                    <a href="lv-354.html" >Hepatitis B</a><span class="carrot"> > </span>
                    <a href="lv-354.html" >Prevention</a><span class="carrot"> > </span>Postexposure Prophylaxis
            </div>
            </br><h4 class="sgc-1" id="sigil_toc_id_358">
 Postexposure Prophylaxis
</h4>
<p>
 Both passive-active PEP (the administration of HBIG and hepatitis B vaccine at separate sites) and active PEP (the administration of hepatitis B vaccination alone) have been demonstrated to be highly effective in preventing transmission&nbsp;after exposure to HBV (4). HBIG alone also has been demonstrated to be effective in preventing HBV transmission, but with the availability of hepatitis B vaccine, HBIG typically is used as an adjunct to vaccination.
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

